Oxford PharmaScience is a specialty pharmaceutical company developing advanced formulation technologies for the global pain-relief market.
Oxford PharmaScience was founded following research collaborations with the University of Oxford. Building on early licensed IP, the company has since developed its own proprietary intellectual property portfolio supporting the OXPzero™ platform.
Our Approach
• Engineered control of onset and systemic exposure
• Clear regulatory pathways leveraging established API safety profiles
• Improved consumer experience through intrinsic taste masking and format flexibility
• Controlled exposure profiles that may support tolerability margins, particularly at higher or repeated doses
We operate an asset-light partnership model, focusing on platform development and regulatory enablement while collaborating with pharmaceutical and consumer health companies for commercialisation.
Current Focus
Oxford PharmaScience is actively partnering with leading companies to develop and commercialize next-generation analgesic products. Our platform technology offers multiple market applications, streamlined development timelines, flexible formulation options, and strong IP protection.
Partnership
For partnership inquiries: contact@pharmascience.co.uk